Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02350114 · ClinicalTrials.gov registry record · NA

An Observational Study of the Functional Capacity of Heart Failure

A NA study of Acute Heart Failure, sponsored by Bristol-Myers Squibb.

Completed
Registry status
NA
Development phase
51
Enrollment target
6
Study locations

NCT02350114 is a NA study of Acute Heart Failure that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 51 participants, below the 1,446-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02350114, a NA study of Acute Heart Failure, has completed, sponsored by Bristol-Myers Squibb.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target
6
Study locations

Study Summary

This is an observational study of the functional capacity of patients with Heart failure with Reduced Ejection Fraction (HFrEF) who are admitted to the hospital for routine medical treatment.

Conditions Studied

Interventions

  • PROCEDURE 6 Minute Walk Test

Study Locations (6)

Michigan

  • Cardioxyl Study Site - Detroit
  • Cardioxyl Study Site - Detroit

Indiana

  • Cardioxyl Study Site - Indianapolis

North Carolina

  • Cardioxyl Study Site - Winston-Salem

Ohio

  • Cardioxyl Study Site - Cincinnati

Tennessee

  • Cardioxyl Study Site - Nashville

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2014-11
Est. Completion 2015-07
Phase NA

Sponsor

Bristol-Myers Squibb

1,025 total trials

What the Registry Record Tells You About NCT02350114

The ClinicalTrials.gov registry entry for NCT02350114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,446-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (96% lower). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which 6 Minute Walk Test is the first listed.

NCT02350114 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Michigan, Indiana, North Carolina.

Frequently Asked Questions

What is clinical trial NCT02350114 about?

NCT02350114 is a clinical study titled "An Observational Study of the Functional Capacity of Heart Failure". This is an observational study of the functional capacity of patients with Heart failure with Reduced Ejection Fraction (HFrEF) who are admitted to the hospital for routine medical treatment.

What is the current status of trial NCT02350114?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2014-11. Estimated completion is 2015-07.

What conditions does trial NCT02350114 study?

This clinical trial studies the following conditions: Acute Heart Failure.

What interventions are being tested in trial NCT02350114?

The interventions under investigation include: 6 Minute Walk Test (PROCEDURE).

Who is sponsoring clinical trial NCT02350114?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02350114 being conducted?

This trial has 6 study locations across Indiana, Michigan, North Carolina, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.